
Phase II trial leads to practice changing milestone for advanced anal cancer
Results from the first ever randomised clinical trial in advanced anal cancer patients, led and…
Results from the first ever randomised clinical trial in advanced anal cancer patients, led and…
A precision medicine targeting a key protein which helps cancer cells to tolerate DNA damage…
Kevin Pollock, Glasgow Caledonian University Cervical cancer is the third most common cancer among women…
Ashish A. Deshmukh, University of Florida; Elizabeth Chiao, Baylor College of Medicine ; Jagpreet Chhatwal,…
A new test, based on a patient’s epigenetics, could be an accurate and inexpensive way…